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Abstract PIAS proteins, cytokine-dependent STAT-associated
repressors, exhibit intrinsic E3-type SUMO ligase activities and
form a family of transcriptional modulators. Three conserved
domains have been identi¢ed so far in this protein family, the
SAP box, the MIZ-Zn ¢nger/RING module and the acidic
C-terminal domain, which are essential for protein interactions,
DNA binding or SUMO ligase activity. We have identi¢ed a
novel conserved domain of 180 residues in PIAS proteins and
shown that its ‘PINIT’ motif as well as other conserved motifs
(in the SAP box and in the RING domain) are independently
involved in nuclear retention of PIAS3L, the long form of
PIAS3, that we have characterized in mouse embryonic stem
cells.
7 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The PIAS (protein inhibitor of activated signal transducer
and activator of transcription (STAT)) protein family con-
tains ¢ve members (PIAS1, PIAS3, PIASxa, PIASxb, PIASy)
essentially identi¢ed through their ability to bind to speci¢c
proteins (transcription factors, Kþ channel, RNA helicase II)
[1^3]. PIAS3 was the ¢rst member discovered as an interleu-
kin-6 (IL-6)-dependent repressor of STAT3 [4]. STATs can be
selectively repressed by association with speci¢c PIAS mole-
cules (e.g. PIAS3/STAT3; PIAS1 or PIASy/STAT1; PIASx/
STAT4) [5,6]. PIAS proteins also coactivate steroid receptor-
dependent transcription [7^9] and modulate the transcription-
al properties of p53 and interferon regulatory factor-1 (IRF-1)
[10^12]. Pro-apoptotic activities of PIAS1 and of a long form
of PIAS3 (PIAS3L/KCHAP) have also been reported, but the
link with their repressive function on gene transcription has
not been established [12^14].
PIAS proteins function as SUMO (small ubiquitin-related
modi¢er)-E3 ligases upon various transcription factors like
STATs, c-jun, IRF-1, p53 and its Mdm2 regulator, and them-
selves [11,15^17]. Sumoylation of transcription factors can
either increase or decrease their activities [18]. However, the
connection between sumoylation and PIAS-dependent repres-
sive function remains elusive. For example, the mutant
STAT1 K703R protein is an active transcription factor that
is repressed by PIAS1 as e⁄ciently as the wild type STAT1
protein, despite its failure to be sumoylated [19].
PIAS proteins contain several conserved domains: the
N-terminal SAP (Saf-A/B, Acinus and Pias) box with the
LXXLL signature, which is required for the trans-repression
of STAT1 activity by PIASy [5,20] ; the MIZ-Zn ¢nger/RING
domain [21], which is essential for SUMO ligase activity; a
C-terminal acidic domain, which is involved in binding of
PIAS3 to the nuclear coactivator TIF2 [8]. The direct inter-
action of PIAS proteins with their sumoylated partners results
in the nuclear translocation of the complex. Sumoylation oc-
curs during the transport from cytosol to nucleus and is some-
times enhanced in the nucleus by other PIAS molecules
[17,22,23].
PIAS translocation from cytosol to cell nucleus might be
dependent on speci¢c domains not yet identi¢ed. The aim of
the present study was to delineate new conserved domains in
this protein family and to establish their role in protein traf-
¢cking.
2. Materials and methods
2.1. Cell culture, transfection and lysates
The mouse embryonic stem (ES) S1 cell line [24] was grown in
STEM medium (high glucose Dulbecco’s modi¢ed Eagle’s medium-
Glutamax with sodium pyruvate; 10% fetal calf serum; 0.1 mM
L-mercaptoethanol), supplemented with 500 pM leukemia inhibitory
factor (LIF); cells were passaged or medium was changed every other
day. COS-1 cells were grown in STEM medium. Transfections were
performed on 10 cm cell Petri dishes with 1^5 Wg of DNA, using
Exgen 500 (Euromedex). ES cell-derived neurons were obtained as
described [25].
Whole cell lysates, a mixture of cytosolic and nuclear lysates at a
2:1 ratio, [26], were resolved by sodium dodecyl sulfate^polyacryl-
amide gel electrophoresis and electro-transferred onto nitrocellulose
membranes in the presence of 0.07% sodium dodecyl sulfate.
2.2. Characterization and cloning of full length mouse pias3L cDNA
Total RNA (1 Wg), prepared from ES cells (Trizol reagent kit; Life
Technologies) [27], was reverse-transcribed (RT) with random hex-
americ primers and MLV reverse transcriptase (Sigma). A quarter
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of the RT was used for each polymerase chain reaction (PCR) reac-
tion with the following oligonucleotides corresponding to sequences of
the mouse pias3 cDNA (set 1) [4] (accession number: AF034080) and
of the complete sequence of rat cDNA (set 2) [14] (accession number:
AF032872).
Set 1: 5P primer: 5P-GCCCTGCACCTCCTCAAGTG-3P, 3P prim-
er: 5P-GGGCTCAGCTCCATTCTTGG-3P.
Set 2: 5P primer: 5P-GGAATTCCATATGGCGGAGCTGGGC-
GAATTAAAGC-3P, 3P primer: 5P-CCCAAGCTTTCAGTCCAAG-
GAAATGACGTC-3P.
2.3. PCR ampli¢cation on di¡erent tissues
PCR reactions were performed on ¢rst strand cDNAs prepared
from 20 mouse tissues (Mouse Rapid-Scan1 Gene Expression Panels,
OriGene Technologies) as recommended by the manufacturer. Thirty-
¢ve cycles of ampli¢cation were performed with actin-speci¢c primers
(control primers included in the kit) or with primers recognizing both
forms of pias3 (accession number: BC023128):
5P primer: 5P-TTGCCCCCTGGCACCTCTCC-3P, 3P primer: 5P-
GGGCTCAGCTCCATTCTTGG-3P.
Expected sizes of PCR products were: pias3, 362 bp; pias3L, 467
bp; L-actin, 570 bp. The identity of each band was con¢rmed by
sequencing.
2.4. Construction of expression vectors
The following Flag-tagged expression vectors, encoding the wild
type PIAS3 (PIAS3-WT) or PIAS3L (PIAS3L-WT) and mutated
forms of PIAS3L proteins, were constructed as follows:
P513-Flag-pias3L-WT: PCR-ampli¢ed fragments, corresponding to
the full length rat pias3L (primer set 2), were cloned, in frame with the
Flag tag, into the NdeI/HindIII sites of the p513-Flag expression
vector, a SV40 promoter-based vector [27].
P513-Flag-pias3-WT: This vector was constructed by looping out
the 105 bp sequence speci¢c to pias3L by site-directed mutagenesis
with the following primers:
5Pprimer: 5P-CCTTGCTTTCTTTGCCCCCTGGCACCTCTCCT-
CCTGTGCACCCCGATGTCACCATGAAGCC-3P, 3P primer: 5P-
GGCTTCATGGTGACATCGGGGTGCACAGGAGGAGAGGTG-
CCAGGGGGCAAAGAAAGC-3P.
P513-Flag-pias3L-mutants: Point or deletion (v) mutations (bold-
faced lettering) were introduced into the full length p513-Flag-pias3L
by site-directed mutagenesis with the following primers. The coordi-
nate of the ¢rst residue of the mutated sequence is indicated, based on
the rat sequence [14].
L19QVLL/AQVAA : 5P primer: 5P-CCGAGTGTCTGAGGCC-
CAGGTGGCCGCCGGCTTCGCTGGC-3P, 3P primer: 5P-GCCAG-
CGAAGCCGGCGGCCACCTGGGCCTCAGACACTCGG-3P.
vP117PLP : 5P primer: 5P-CCTAAGCGTGAGGTGGCAATGCA-
TCAGCCTGTGCACCCCGATGTCACC-3P, 3P primer: 5P-GGTG-
ACATCGGGGTGCACAGGCTGATGCATGTCCACCTCACGCT-
TAGG-3P.
PI242NIT/PSDST: 5P primer: 5P-CCAAGAGGCCCAGCCGTCC-
GAGCGACAGCACACCCTTGGCTCG-3P, 3P primer: 5P-CGAGC-
CAAGGGTGTGCTGTCGCTCGGACGGCTGGGCCTCTTGG-3P.








Each construct was veri¢ed by sequencing.
2.5. PIAS3L-speci¢c antibody and immunodetection
A PIAS3L-speci¢c rabbit polyclonal antibody (Ab 1395) was raised
by repeated injection of an ovalbumin-coupled peptide
(TPGTLLGPKREVDMHPPLPQ), present only in the large variant
of PIAS3 (PIAS3L).
Antibody synthesis : 300 Wg of peptide (in a 1:1 phosphate-bu¡ered
saline (PBS)/complete Freund adjuvant emulsion) was injected in
anesthetized New Zealand female rabbit as 70 intradermal indulation
points, with a glass syringe. One month later, 40 ml of blood was
drawn every week four times and the serum was tested by Western
blot on COS-1 cells transfected with p513-Flag-pias3L. The rabbit
was then boosted with 150 Wg of peptide (in a 1:1 PBS/incomplete
Freund adjuvant emulsion) and killed 12 days later, under anesthesia.
Before injection of the speci¢c peptide, 5 ml of blood, drawn from the
ear artery, was used to derive the pre-immune serum from the same
rabbit.
Immunoprecipitation: Total cell lysates (200 Wg protein in 1 ml of
Tris-bu¡ered saline (TBS)) were precleared with 40 Wl of a 50% (v/v)
protein A Sepharose slurry for 1 h at 4‡C. The supernatant was in-
cubated with 10 Wl of Ab 1395 or pre-immune sera for 1 h and reacted
with 40 Wl of protein A Sepharose for another 1 h. The recovered
beads were washed three times with ice-cold TBS, 0.1% NP40. Flag-
tagged proteins were immunoprecipitated following the same proce-
dure with 30 Wl of anti-Flag M2 a⁄nity gel (Sigma).
2.6. Immunocytochemistry
COS-1 cells were transfected with 2 Wg of p513-Flag-pias3 or pias3L
constructs. Cells were ¢xed with 4% formaldehyde in PBS for 10 min
at room temperature and permeabilized with 0.1% Triton X-100 for
20 min. Fixed cells were rinsed with PBS and incubated with blocking
bu¡er (PBS, 3% bovine serum albumin (BSA), 0.1% Triton X-100) for
1 h, followed by incubation with the primary antibodies at room
temperature for 1 h in PBS with 5% BSA and 0.1% Triton X-100.
After washing with PBS, cells were incubated for 1 h with species-
Fig. 1. Alignment of PIAS family members. PIAS proteins, with their indicated GenBank accession numbers (Mmu=Mus musculus ; Rat=Rat-
tus norvegicus; Hu=Human), have been aligned with the ‘multAlin’ software. Highly conserved residues are in red, low consensus residues in
blue and neutral residues in black. In the consensus line, # indicates E or D, % indicates F or Y, $ indicates L or M and ! indicates I or V.
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Fig. 2. Di¡erential expression pro¢les of pias3 and pias3L. PCR experiments, with primers recognizing both pias3 and pias3L cDNAs and with
control actin primers, were performed on a commercially available subset of tissues with the ‘Rapid Scan’ kit. One quarter of each PCR reac-
tion was run on a 2% agarose gel and the identity of each band veri¢ed by DNA sequencing. Arrows points to the speci¢c PCR products.
‘Negative control’ was performed in the absence of DNA. ‘Positive control’ corresponds to a PCR reaction performed with a mixture of 1 pg
of p513-Flag-pias3 and pias3L plasmid DNAs.
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speci¢c £uorescence-labeled secondary antibodies. Samples were
washed twice with PBS, counterstained with Hoechst 33258 for 10 s
and mounted in 75% glycerol, 20% PBS and 5% propylgallate. Anti-
bodies were diluted as followed: rabbit Ab 1395 (1/200), mouse mono-
clonal anti-Flag M2 (1/500), anti-mouse or anti-rabbit IgG-Cy3
(1/300, Jackson Immunoresearch).
2.7. Computer analysis
Protein alignments were performed with the multAlin (Infobiogen
site: http://www.infobiogen.fr/services/deambulum [28]) and the Pipe-
Align (IGBMC site: http://www-igbmc.u-strasbg.fr [29]) software.
The di¡erent protein sequences were retrieved from GenBank and
pasted into the ‘multAlin’ windows (for Fig. 1). Sequence alignments
were achieved using PipeAlign and re¢ned manually to maximize se-
quence conservations and the superposition of the predicted second-
ary structures, using the PHD software [30] for each individual se-
quence (for Fig. 4).
3. Results and discussion
3.1. Cloning of a novel variant of pias3 cDNA (pias3L) from
mouse ES cells
To characterize additional STAT3 repressors from mouse
ES cells, we performed RT-PCR analyses with total RNA and
primers corresponding to the pias3 gene (set 1, Section 2). A
major ampli¢cation product was obtained, which revealed an
insertion of 105 bp, in comparison with the already reported
pias3, corresponding to a 35 amino acid in-frame extension of
the PIAS3 protein. Data base search performed with the
cDNA fragment revealed that it was identical to the rat Kchap
cDNA which encodes a Kþ channel-associated protein that
had previously been cloned by double-hybrid screen from a
rat brain cDNA library [31]. A mouse cDNA corresponding
to an extended form of pias3 (named pias3L) has recently
been reported [12]. The nucleotide and protein sequences of
this cDNA are identical to our sequence between amino acids
10 and 628, but it lacks the ¢rst nine residues present in our
mouse ES cDNA clone, as well as in the Kchap rat homologue
and in a recently released mouse cDNA sequence (accession
number BC051252). Comparison of protein sequences of var-
ious PIAS proteins allowed us to identify the initiation codon,
10 residues upstream of the previously de¢ned start codon of
PIAS3, and a conserved insertion element, absent from the
originally cloned pias3 cDNA (Fig. 1). This element, which
corresponds to a retained intron ([14] and our unpublished
results) and encodes a 35 (in PIAS3L) or 49 (in PIASXa/b)
residue sequence, is poorly conserved among the di¡erent
PIAS proteins but is surrounded by two highly conserved
blocks, GXSP and PVHPDV (Fig. 1).
3.2. Di¡erential expression pattern of pias3 and pias3L in
mouse tissues
The fact that only pias3L, but not pias3, was originally
detected in mouse ES cells prompted us to characterize the
expression pro¢le of pias3 and pias3L in di¡erent tissues with
primers recognizing both forms (see Section 2). Except for
muscle, lung and testis, where both forms were about equally
present, di¡erential expression was observed in all other tis-
sues assayed (Fig. 2). We also con¢rmed that the major form
present in ES cells is pias3L. We also found that pias3L is
present in lactating breast but not in virgin, pregnant or in-
voluting breast (Fig. 2). The signi¢cance of regulated co-ex-
pression or exclusive expression of these di¡erent pias3 forms
is presently unknown.
3.3. Characterization of the PIAS3L protein
To verify that the protein corresponding to the pias3L tran-
script was actually synthesized, Western blot experiments were
performed, using protein extracts from cells transfected with
p513-Flag vectors encoding the PIAS3 or PIAS3L proteins.
While the pre-immune serum recognized non-speci¢c bands in
the di¡erent cell lysates, a polyclonal antibody (Ab 1395)
directed against a peptide sequence unique to PIAS3L (Sec-
tion 2) speci¢cally reacted with the FLAG-PIAS3L but not
with the FLAG-PIAS3 proteins (Fig. 3A). When the same
lysates were reacted with the anti-Flag antibody, the presence
Fig. 3. Characterization of PIAS3L protein with a PIAS3L-speci¢c
polyclonal antibody. A: Western blot analysis was performed on 50
Wg of total cell lysates from COS-1 cells (mock or transfected with
p513-Flag-pias3 or pias3L encoding vectors) with the pre-immune
or Ab 1395 polyclonal antibodies, as indicated. The arrow points to
the position of the PIAS3L protein. B: The same lysates as above
were either probed directly with the anti-Flag antibody (Flag) or
after immunoprecipitation (200 Wg) with 5 Wg/ml of mouse anti-Flag
(IP Flag) or with 10 Wl of the rabbit polyclonal Ab 1395 (IP 1395)
antibodies. C: Total cell lysates derived from mouse ES cells (50
Wg; ES), ES-derived neurons (50 Wg) and COS-1 cells overexpressing
transfected FLAG-PIAS3L (10 Wg; Cos-Transf.) were probed with
the 1395 polyclonal antibody (Ab 1395).
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of PIAS3 or PIAS3L proteins was revealed in the correspond-
ing extracts, as expected (Fig. 3B, top). Immunoprecipitation
of cell lysates with the anti-Flag or Ab 1395 sera also revealed
the proteins, further stressing the speci¢city of the anti-
PIAS3L Ab 1395 antibody (Fig. 3B, middle and bottom).
The endogenous PIAS3L protein was also detected in mouse
ES and in ES cell-derived neuron lysates (Fig. 3C).
PIAS3 has previously been shown to interact with STAT3
proteins in IL-6-stimulated cells [4]. We did not, however,
detect any interaction between STAT3 and PIAS3 or PIAS3L
in mouse ES cells, whether LIF-induced or not (our unpub-
lished observation). This might be related to the fact that
STAT3 does not interact with PIAS3 when this protein is
associated with particular proteins in the nucleus, such as
the MITF protein [32].
3.4. Identi¢cation of a novel protein module, including the
conserved ‘PINIT’ motif, in the PIAS family
The presence of a new domain in the PIAS3L protein,
compared to PIAS3, led us to perform a deeper analysis of
protein domain conservation between the di¡erent PIAS iso-
forms. Such a study may help to characterize new members of
the growing PIAS family and to de¢ne essential protein do-
mains involved in PIAS functions. Using the PipeAlign soft-
ware [29] we de¢ned a well conserved new protein domain of
181 amino acids, which we named the ‘PINIT domain’. This
domain starts at the PFY motif (position 133 of PIAS3L) and
ends at an acidic residue (E or D) at position 315. Among
di¡erent protein motifs that are conserved within this domain,
we have identi¢ed the ‘PINIT’ motif (position 241 of PIAS3L)
as a hallmark of this newly de¢ned domain (Fig. 4). This
Fig. 4. Characterization of the ‘PINIT’ domain in PIAS proteins. Multiple alignment of the ‘PINIT’ domain sequences in PIAS proteins was
done with PipeAlign and subsequently corrected manually based on secondary structure elements. The designation of each protein includes the
species abbreviation followed by the gene name or the accession number (or the SwissProt database name when available), ‘frag’ indicates that
the sequence corresponds to a protein fragment. Expressed sequence tags (ESTs) are designated by their GenBank accession number. The num-
bers at the beginning and at the end of each sequence indicate the positions of the ¢rst and last of the aligned residues in the respective protein
sequence; the number in parentheses at the end of each sequence indicates the number of residues remaining after the last shown position. The
shading of conserved residues is according to the consensus and includes residues conserved in at least 85% of the aligned sequences. In the
consensus line, h indicates hydrophobic residues (A,C,F,I,L,M,V,W,Y,T,S,G; yellow background); s indicates small residues (A,C,S,T,D,V,G,P;
green background, white letters); c indicates charged residues (D,E,H,K,R; pink background); p indicates polar residues (D,E,H,K,N,Q,R,S,T;
blue letters) and strictly conserved residues are shown by inverse shading (white against a black background). The predicted secondary structure
elements were positioned using the PHD program on the multiple alignment and are indicated below the alignment (a indicates K-helix; b indi-
cates L-strand). Abbreviations: Ag, Anopheles gambiae ; Am, Apis mellifera ; At, Arabidopsis thaliana ; Bm, Bombyx mori ; Ce, Caenorhabditis
elegans ; Ci, Ciona intestinalis ; Dd, Dictyostelium discoideum ; Dm, Drosophila melanogaster ; Dv, Dermacentor variabilis ; Hs, Homo sapiens ;
Mm, Mus musculus; Nc, Neurospora crassa ; Os, Oryza sativa ; Rn, Rattus norvegicus ; Sc, Saccharomyces cerevisiae ; Sp, Schizosaccharomyces
pombe ; Vc, Vicia faba.
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Fig. 5. Independent conserved domains of PIAS3L are involved in its nuclear retention. A: General features of PIAS proteins are represented
(not to scale) with coordinates referring to PIAS3L (accession number: BC051252). Within each structured domain (colored boxes), important
motifs are boldfaced. B: The structures of the wild type (WT) PIAS3 or WT and mutated PIAS3L proteins are represented with the same color
code as in A. The non-conserved sequences are represented by spaces separating the colored boxes. The name of each mutant and the precise
nature of the mutations are indicated. Subcellular localizations of these proteins (overexpressed in COS-1 cells) are also indicated. C: Immuno-
staining of mock or transfected COS-1 cells with the di¡erent p513-Flag vectors, with the Cy3 secondary antibodies revealing the primary Ab
1395 (endogenous PIAS3L) or Flag antibodies. Cell nuclei were directly labelled with Hoechst 33258. Visualization of the £uorescence sepa-
rately or overlaid is presented. Magni¢cation is U400.
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domain is well conserved among all vertebrate PIAS family
members, as well as in PIAS-like proteins characterized in
invertebrates up to yeast.
3.5. Conserved domains, including the newly de¢ned ‘PINIT’
motif, are involved in nuclear localization of the PIAS3L
protein
Protein tra⁄cking between nucleus and cytosol is essential
for some of the PIAS activities and we have searched for
domains involved in di¡erential PIAS3L protein localization.
First of all, it was of interest to determine if PIAS3 and
PIAS3L have similar cellular localizations. We also investi-
gated the e¡ect of mutations in previously de¢ned PIAS do-
mains (like the SAP box and the RING domain) in the con-
text of the PIAS3L protein. Finally, the importance of the
‘PINIT’ motif for protein localization was analyzed.
The p513-Flag-pias3L vector and its derivatives were trans-
fected in COS-1 cells. The general features of the PIAS pro-
teins with the positions of each domain given with respect to
the PIAS3L sequence and of the PIAS3 variants expressed
from the p513-Flag vectors are presented (Fig. 5A,B). A rep-
resentative selection of immunostained COS-1 cells is shown
in Fig. 5C.
The endogenous PIAS3L protein is mainly detected as dots
in the cell nucleus, in agreement with previous studies showing
a speckled nuclear staining pattern of PIAS1 [23], or PIASy
[22]. The overexpressed wild type PIAS3 and PIAS3L, as well
as the vPPLP mutant, were strictly nuclear and mainly lo-
cated in regions excluding condensed chromatin. By contrast,
the localization of PIAS3L mutants, altered either within the
N-terminal LQVLL motif, the MZ-Zn ¢nger/RING domain
or the newly de¢ned ‘PINIT’ motif, was disrupted: the over-
expressed mutant proteins are no longer restricted to the nu-
cleus. This clearly indicates that separate motifs, present with-
in the SAP box, the MZ-Zn ¢nger/RING or the PINIT
domains, are essential for nuclear localization and suggests
that PIAS3L may be part of independent subcomplexes
formed with di¡erent nuclear partners.
In conclusion, besides bringing new insights into the struc-
ture of PIAS3 and PIAS3L, this study reveals that both forms
may coexist in various tissues, while exclusive expression of
one or the other form was observed in some speci¢c organs.
In addition, awareness about a new structured domain in
PIAS proteins will help to characterize the di¡erent PIAS-
containing subcomplexes involved in the multiple functions
of this protein family.
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